CTOR (STOCKS)
Citius Oncology, Inc. Common Stock
$0.820000
+0.008500 (+1.05%)
Prev close: $0.811500
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Leonard L. Mazur
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $99.77M
- Employees
- —
- P/E (TTM)
- -1.74
- P/B (TTM)
- 2.14
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q2)
|
$-0.27 | $-0.01 | -0.2598 | -2,547.06% |
|
Dec 2025 (Q1)
|
$-0.06 | $0.06 | -0.1212 | -198.04% |
|
Sep 2025 (Q4)
|
$-0.06 | $-0.12 | +0.0624 | +50.98% |
|
Jun 2025 (Q3)
|
$-0.08 | $-0.15 | +0.0730 | +47.71% |
Financial Statements
| Revenues | $5.61M |
| Operating Expenses | $48.02M |
| Research and Development | $4.11M |
| Other Operating Expenses | $43.90M |
| Operating Income/Loss | -$43.52M |
| Income/Loss From Continuing Operations After Tax | -$42.51M |
| Income/Loss From Continuing Operations Before Tax | -$41.95M |
| Income Tax Expense/Benefit | $561.51K |
| Income Tax Expense/Benefit, Deferred | $561.51K |
| Net Income/Loss | -$42.51M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$42.51M |
| Net Income/Loss Available To Common Stockholders, Basic | -$42.51M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.47 |
| Diluted Earnings Per Share | -$0.47 |
| Basic Average Shares | 260,757,558 |
| Diluted Average Shares | 260,757,558 |
| Assets | $100.70M |
| Current Assets | $29.42M |
| Inventory | $22.66M |
| Prepaid Expenses | $3.05M |
| Other Current Assets | $3.71M |
| Noncurrent Assets | $71.28M |
| Liabilities | $65.43M |
| Current Liabilities | $58.81M |
| Accounts Payable | $8.88M |
| Other Current Liabilities | $49.93M |
| Noncurrent Liabilities | $6.62M |
| Equity | $35.27M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $35.27M |
| Liabilities And Equity | $100.70M |
| Comprehensive Income/Loss | -$42.51M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$42.51M |
| Other Comprehensive Income/Loss | $0.00 |